These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8260751)
1. Effect of Bcl-2 on ionizing radiation and 1-beta-D-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells. Manome Y; Weichselbaum RR; Kufe DW; Fine HA Oncol Res; 1993; 5(3):139-44. PubMed ID: 8260751 [TBL] [Abstract][Full Text] [Related]
2. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis. Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329 [TBL] [Abstract][Full Text] [Related]
3. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine. Gunji H; Kharbanda S; Kufe D Cancer Res; 1991 Jan; 51(2):741-3. PubMed ID: 1985792 [TBL] [Abstract][Full Text] [Related]
4. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells. Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016 [TBL] [Abstract][Full Text] [Related]
5. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Grant S; Turner AJ; Bartimole TM; Nelms PA; Joe VC; Jarvis WD Oncol Res; 1994; 6(2):87-99. PubMed ID: 7949469 [TBL] [Abstract][Full Text] [Related]
6. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Bcl-XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Datta R; Manome Y; Taneja N; Boise LH; Weichselbaum R; Thompson CB; Slapak CA; Kufe D Cell Growth Differ; 1995 Apr; 6(4):363-70. PubMed ID: 7794804 [TBL] [Abstract][Full Text] [Related]
8. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide. Chen M; Quintans J; Fuks Z; Thompson C; Kufe DW; Weichselbaum RR Cancer Res; 1995 Mar; 55(5):991-4. PubMed ID: 7867010 [TBL] [Abstract][Full Text] [Related]
9. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Vanhaesebroeck B; Reed JC; De Valck D; Grooten J; Miyashita T; Tanaka S; Beyaert R; Van Roy F; Fiers W Oncogene; 1993 Apr; 8(4):1075-81. PubMed ID: 8455935 [TBL] [Abstract][Full Text] [Related]
10. Induction of BCL2 family member MCL1 as an early response to DNA damage. Zhan Q; Bieszczad CK; Bae I; Fornace AJ; Craig RW Oncogene; 1997 Mar; 14(9):1031-9. PubMed ID: 9070651 [TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Walton MI; Whysong D; O'Connor PM; Hockenbery D; Korsmeyer SJ; Kohn KW Cancer Res; 1993 Apr; 53(8):1853-61. PubMed ID: 8467505 [TBL] [Abstract][Full Text] [Related]
12. The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism. Ito Y; Pandey P; Place A; Sporn MB; Gribble GW; Honda T; Kharbanda S; Kufe D Cell Growth Differ; 2000 May; 11(5):261-7. PubMed ID: 10845427 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993 [TBL] [Abstract][Full Text] [Related]
14. Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine. Henschler R; Brennscheidt U; Mertelsmann R; Herrmann F Mol Pharmacol; 1991 Feb; 39(2):171-6. PubMed ID: 1996082 [TBL] [Abstract][Full Text] [Related]
15. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P; Lien EJ; Avramis VI Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093 [TBL] [Abstract][Full Text] [Related]
17. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2. Hedley DW; McCulloch EA Leukemia; 1996 Jul; 10(7):1143-9. PubMed ID: 8683994 [TBL] [Abstract][Full Text] [Related]
18. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Miyashita T; Reed JC Cancer Res; 1992 Oct; 52(19):5407-11. PubMed ID: 1394146 [TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis. Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557 [TBL] [Abstract][Full Text] [Related]
20. Regulation of jun-B gene expression by 1-beta-D-arabinofuranosyl-cytosine in human myeloid leukemia cells. Datta R; Kharbanda S; Kufe D Mol Pharmacol; 1990 Oct; 38(4):435-9. PubMed ID: 2122229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]